Three-Pronged attack on tough liver cancer
NCT ID NCT07432568
Summary
This study is testing a new combination treatment for people with advanced bile duct cancer in the liver that cannot be treated with surgery. The treatment combines three approaches: chemotherapy delivered directly to the liver, a daily pill that targets the tumor's blood supply, and an immunotherapy drug given by IV. The main goal is to see how many patients' tumors shrink or disappear with this approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAHEPATIC CHOLANGIOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.